Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.

Elisa Martín MerinoI PetersenS HawleyA Álvarez-GutierrezS KhalidA Llorente-GarciaA DelmestriM K JavaidT P Van StaaA JudgeC CooperD Prieto-Alhambra

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2017)

VTE risk during AO therapy did not differ by AOM drug use. Our data does not support an increased risk of VTE associated with strontium ranelate use in the community.

Keyphrases

venous thromboembolism
direct oral anticoagulants
healthcare
postmenopausal women
mental health
electronic health record
bone mineral density
big data
stem cells
data analysis
artificial intelligence
drug induced
cell therapy